| 2023 | Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants | Sun, CP ; Chiu, CW; Wu, PY; Tsung, SI; Lee, IJ; Hu, CW; Hsu, MF; Kuo, TJ; Lan, YH; Chen, LY; Ng, HY; Chung, MJ; Liao, HN; Tseng, SC; Lo, CH; Chen, YJ; Liao, CC ; Chang, CS; Liang, JJ; Draczkowski, P; Puri, S; Chang, YC ; Huang, JS; Chen, CC; Kau, JH; Chen, YH ; Liu, WC ; Wu, HC ; Hsu, STD ; Wang, IH ; Tao, MH | Molecular Therapy 31(11), 3322-3336 | | | |
| 2022 | Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants | Lee, IJ; Sun, CP; Wu, PY; Lan, YH; Wang, IH ; Liu, WC ; Tseng, SC; Tsung, SI; Chou, YC ; Kumari, M; Chang, YW; Chen, HF; Lin, YS; Chen, TY; Chiu, CW; Hsieh, CH; Chuang, CY; Lin, CC; Cheng, CM; Lin, HT; Chen, WY; Chiang, PC; Lee, CC; Liao, JC; Wu, HC ; Tao, MH | BioRxiv | | | |
